Literature DB >> 6822934

Quantitative cultures of middle-ear fluid in acute otitis media.

E R Wald, D D Rohn, D M Chiponis, M M Blatter, K S Reisinger, F P Wucher.   

Abstract

Entities:  

Mesh:

Year:  1983        PMID: 6822934     DOI: 10.1016/s0022-3476(83)80536-8

Source DB:  PubMed          Journal:  J Pediatr        ISSN: 0022-3476            Impact factor:   4.406


× No keyword cloud information.
  6 in total

1.  Rationale behind high-dose amoxicillin therapy for acute otitis media due to penicillin-nonsusceptible pneumococci: support from in vitro pharmacodynamic studies.

Authors:  P D Lister; A Pong; S A Chartrand; C C Sanders
Journal:  Antimicrob Agents Chemother       Date:  1997-09       Impact factor: 5.191

2.  Determination of the epidemiology and transmission of nontypable Haemophilus influenzae in children with otitis media by comparison of total genomic DNA restriction fingerprints.

Authors:  B G Loos; J M Bernstein; D M Dryja; T F Murphy; D P Dickinson
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

Review 3.  Branhamella catarrhalis: an organism gaining respect as a pathogen.

Authors:  B W Catlin
Journal:  Clin Microbiol Rev       Date:  1990-10       Impact factor: 26.132

4.  A protective epitope of Moraxella catarrhalis is encoded by two different genes.

Authors:  C Aebi; I Maciver; J L Latimer; L D Cope; M K Stevens; S E Thomas; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1997-11       Impact factor: 3.441

5.  A major outer membrane protein of Moraxella catarrhalis is a target for antibodies that enhance pulmonary clearance of the pathogen in an animal model.

Authors:  M E Helminen; I Maciver; J L Latimer; L D Cope; G H McCracken; E J Hansen
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

6.  An in vitro pharmacodynamic model to simulate antibiotic behavior of acute otitis media with effusion.

Authors:  K Vance-Bryan; T A Larson; M W Garrison; J P Toscano; D M Canafax; J C Rotschafer
Journal:  Pharm Res       Date:  1992-07       Impact factor: 4.200

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.